Sensus Hlthcr

SRTS NASDAQ
6.36
+0.08
+1.27%
After Hours: 6.28 -0.08 -1.26% 16:00 08/16 EDT
Open
6.28
Prev Close
6.28
High
6.46
Low
6.28
Volume
15.01K
Avg Vol (3M)
19.14K
52 Week High
9.23
52 Week Low
4.750
% Turnover
0.09%
Market Cap
104.92M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Sensus Hlthcr SRTS stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Sensus Healthcare, Inc., formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The superficial radiation therapy is an alternative to surgical basal cell carcinoma treatment and squamous cell carcinoma treatment. The Company's product, the SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions, such as keloids. The SRT-100 treats primary lesions that would otherwise be difficult or require surgery involving sensitive areas of the head and neck regions, such as the fold in the nose, eyelids, lips, corner of the mouth and the lining of the ear.
MORE >

Recently

Name
Price
%Change